Navigation Links
Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007
Date:9/6/2007

1,000 16,177

Net Investment Loss/(Gain) 583 (16,013)

Gain on Settlement, Net of Return of Inventory (1,150) --

Loss from Discontinued Operations -- 42,975

Resolution of Tax Contingencies -- (7,218)

Estimated Tax on Adjustments (9,466) (15,909)

Adjusted Net Income (non-GAAP measure) $21,548 $4,703

Diluted Earnings (Loss) Per Share:

Reported $0.19 $(0.44)

Adjusted (non-GAAP measure) $0.62 $ 0.14


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire-FirstCall/-- OnyxPharmaceuticals,Inc.(N...woinvestoreventsinDecember: ,, ASHBriefing ..., Principalinvestigatorswilldiscussdatapresentat...rymultiplemyeloma,asfeaturedatthe51stAmericanSocie...Orleans,LA.Theteleconferencewillbeginat9:00a.m.CT/...
(Date:11/25/2009)...Newswire/--Thanksgivingmealswillbedeliveredtoappro...areathankstoFaithInAction/VolunteerActionforAging,...nofSCANHealthPlan.Formorethan17yearstheseorganizat...hanksgivingmealstoseniorsinneedinLongBeach,Lakewoo...gcities. ,, "Ourwarmholidaymealsaredeliveredtop...
(Date:11/25/2009)...wire/--TheBayAreaAirQualityManagementDistrictisiss... Alert forThursday,November26,2009whichbansbu...bothindoorsandoutdoors. ,, "Cold,stillweatherwi...kBroadbent,executiveofficeroftheAirDistrict."We,re...ghborsandfellowcommunitymembersthisThanksgiving,an...
(Date:11/25/2009)...of a statistically significant survival benefit fr...n receptor (ER)-positive tumors had high levels of...pha S118-P), according to a brief communication pu...National Cancer Institute . , Approximately 50% ...reclinical studies have shown that ER-alpha S118-P...
(Date:11/25/2009)... short to draw definite conclusions, experts say,... -- In diabetic patients with blocked coronary art...es at one year whether patients undergo bypass sur...hers report. , Bypass surgery has been the stan... artery disease. However, less invasive approaches...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
... coli having raised its ugly head, many thousands ...g to completely stop// using tap water that has no...rities having detected EColi presence in the sampl...ommunities. County Executive Steve Levy said...
...nd to benefit with calcium supplements, according ...on Cancer Research Center have been able to unders...ight gain after analyzing the health statistics ne...re evidence from randomized clinical trials is nee...
...sed extensively in cough syrups, is actually no be...ew study. The drug seems to deal effectively with .../. Manchester University researchers conducte... Immunology. The researchers found that patients w...
...important role in the development of cancer. Prote...in the cancer development//. It is found that...owth. In the book titled The China Study which is ...s evident. Dr. T. Colin Campbell a nutrition profe...
...ve successfully separated a conjoined twin girls i...port said today//. One of the conjoined twi...are trying all out to help her live through her cr...en Jingni were separated during an operation lasti...
...major public health threat posed by antibiotic-res...California, San Diego (UCSD) are launching a new p...al discovery, through development and testing, to ...lor Marye Anne Fox. "UCSD researchers in medicine,...
Other Medicine News:Health News:Too Much Of Animal Protein May Lead To Cancer 2Health News:New UCSD Program to Fight Drug-Resistant Bacteria 2Health News:New UCSD Program to Fight Drug-Resistant Bacteria 3Health News:New UCSD Program to Fight Drug-Resistant Bacteria 4
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, IntranasalDrugDelivery-USMarketTre...4267/Intranasal-Drug-Delivery---US-Market-Trends--...rketiswitnessinganexpansionoftherapeuticapplicatio...gstothedeliveryofsystemictherapeuticdrugs.Thefutur...
(Date:11/25/2009)... MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCe...tafromtheCompany,sPROTECT-1(theProspectiveRandomiz...ficet-EN(TM)(CCX282-B)inpatientswithmoderate-to-se...afavorablesafetyandtolerabilityprofile.Thestudydem...fdiseaseseverityasdefinedasa70-pointdecreaseintheC...
(Date:11/24/2009)... IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endol...ivetreatmentsforaorticdisorders,announcedtodaythat...sin,thepatentinfringementlawsuitbroughtagainstitin...StatesDistrictCourtinIndianapolis,Indiana. ,, E...theUnitedStatesPatentandTrademarkOffice(USPTO)cond...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 1Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 2Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 3First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 1First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 1Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 3
...EY, April 24 HeartWare International, Inc. (Nasda...ults for its international clinical trial of the H...esults were presented by Dr. Martin Strueber, card...the annual meeting of the International Society fo...aris this week. A full copy of the presentation wa...
...ers at Tufts Medical Center have created a formula...with certain genetic profiles and lifestyle behavi...neration (AMD), a potentially blinding condition t...er Americans and is increasing dramatically as the...M. Seddon, MD, ScM, Professor of Ophthalmology at ...
Other Medicine Technology:HeartWare International Clinical Trial Shows 90% Survival at 180 Days 2HeartWare International Clinical Trial Shows 90% Survival at 180 Days 3Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD) 2
Ocuvite® Lutein Eye Vitamin and Mineral Supplements
...ext-generation dietary supplement from the invento...s the root inflammatory cause and effects of dry e...rature that these specific nutrients support norma... of the body, such as mucous membranes of the mout...
Unity Desktop
Vision Premier Holter System
Medicine Products: